French Observatory of Rare Malignant Tumors of the Ovary

Observatoire Francophone Des Tumeurs Malignes Rares de l'Ovaire : Protocole de Prise en Charge Chez l'Adulte (Tumeurs Germinales et Des Cordons Sexuels)

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01304043

Enrollment

204

Registered

2011-02-25

Start date

2002-01-31

Completion date

2011-06-30

Last updated

2012-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovarian Tumors

Keywords

ovarian tumors, rare ovarian tumors, germinal tumors, sexual cords tumors, observatory, forum

Brief summary

To take charge of the treatment in rare adult ovarian tumors with an homogenous manner (germinal and sexual cords tumors), at different stages of the disease.

Detailed description

* to establish prognosis factors for the disease * to proceed in a centralised examination of histologic laminas * to reach in the long-term and homogenous follow-up of the patients * to follow-up the long-term toxicities of the treatments given * to analyse and follow-up the later fertility of the patients * to evaluate the interest of setting a multi-disciplinary discussion forum on the Web

Interventions

DRUGchemotherapies protocols

Cisplatine 20 mg/m² IV Etoposide 100 mg/m² IV Bléomycine 30 mg IV

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* age \> 18 years old * germinal or sexual cords ovary tumors histologically proven * first line or relapse treatment * written informed consent

Exclusion criteria

* mental ineptitude to understand and follow the study

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026